Surjit Bhimarao Dixit
Geen lopende functies
Loopbaan van Surjit Bhimarao Dixit
Eerdere bekende functies van Surjit Bhimarao Dixit
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Wesleyan University | Corporate Officer/Principal | 01-01-2005 | 01-07-2007 |
| Henri Poincaré University | Corporate Officer/Principal | 01-10-1999 | 01-02-2001 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Hoofd Techniek/Wetenschap/O&O | 01-07-2007 | - |
Opleiding van Surjit Bhimarao Dixit
| Indian Institute of Technology New Delhi | Doctorate Degree |
Statistieken
Internationaal
| Canada | 2 |
| India | 2 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
